Skikos Crawford Skikos & Joseph Provides Yaz Lawsuit Settlement Update, Continues to Evaluate New Claims - FOX19.com-Cincinnati News, Weather & Sports

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE: Skikos Crawford Skikos & Joseph

Victims of blood clots who used Yaz, Yasmin, Ocella, and Gianvi have already received Yaz lawsuit settlements. Visit http://www.lawsuit-yaz.com to learn more and consult an experienced Yaz lawyer at no cost.

San Francisco, CA (PRWEB) December 05, 2012

On October 30, 2012, Bayer issued its Stockholders’ Newsletter for the third quarter of 2012 (http://www.stockholders-newsletter-q3-2012.bayer.com). The company disclosed that it has paid $750 million to settle approximately 3,490 lawsuits involving the Yaz, Yasmin, Gianvi, and Ocella birth control pills. These figures indicate an average Yaz lawsuit settlement amount of $215,000 per case.

Skikos Crawford Skikos & Joseph is a nationally recognized leader in defective drug litigation, and represents clients pursuing Yaz settlements. At the present time, the Yaz litigation is ongoing. Accordingly, the firm’s Yaz lawyers continue to provide free and confidential evaluations of potential Yaz, Yasmin, Gianvi, and Ocella lawsuits. Readers can learn more about the nationwide Yaz litigation and consult an experienced Yaz attorney via the firm’s website.

In its Stockholders’ Newsletter, Bayer informed investors that it would only negotiate settlements with victims of alleged Yaz blood clot injuries. Accordingly, women who suffered a blood clot or related injury such as pulmonary embolism (PE), deep vein thrombosis (DVT), or stroke after using Yaz, Yasmin, Gianvi, or Ocella may receive settlement proceeds. While other types of injuries could be associated with these pills, such as gallbladder disease or seizure, Bayer’s settlement offers are limited to alleged Yaz blood clots and related health effects such as stroke, PE, or DVT. More information can be found in the current FDA safety warning about Yaz blood clots and the risk of stroke, pulmonary embolism, and deep vein thrombosis associated with the Yaz line of birth control pills.

While Bayer’s announcement of Yaz lawsuit settlement amounts provides an indication of potential recovery, each case must be evaluated on its merits by an experienced Yaz lawyer. Skikos Crawford Skikos & Joseph encourages individuals with a potential Yaz lawsuit, Yasmin lawsuit, Ocella lawsuit, or Gianvi lawsuit to consult a qualified attorney and safeguard their legal rights.

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2012/12/prweb10141870.htm